# Prophylactic Treatment With Oseltamivir

> **NCT03899571** · NA · COMPLETED · sponsor: **University Medical Centre Ljubljana** · enrollment: 222 (actual)

## Conditions studied

- Influenza, Human

## Interventions

- **DRUG:** Oseltamivir Oral Capsule for 5 days post-exposure
- **DRUG:** Oseltamivir Oral Capsule for 10 days post-exposure

## Key facts

- **NCT ID:** NCT03899571
- **Lead sponsor:** University Medical Centre Ljubljana
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-22
- **Primary completion:** 2020-03-31
- **Final completion:** 2020-03-31
- **Target enrollment:** 222 (ACTUAL)
- **Last updated:** 2020-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03899571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03899571, "Prophylactic Treatment With Oseltamivir". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03899571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*